drugset / Trial / NCT02760979

The Efficacy of Denosumab in Decreasing Periprosthetic Bone Loss in Patients With Total Knee Arthroplasty

NCT02760979

Phase 4 Completed 60 enrolled Sant Pau Research Institute
RandomizedParallel-groupTriple-blindPrevention

Summary

This study evaluates the effect of Denosumab in decreasing the periprosthetic bone resorption after Total Knee Arthroplasty compared to placebo in 60 patients (30 placebo and 30 Denosumab) within a year after surgery.

Timeline

Start
2013-01
Primary completion
2014-01
Completion
2015-06

Drugs

EvaluationDrugModalityDoseRoute
Comparator Denosumab Monoclonal antibody